Clinical trials sponsored by Qilu Pharmaceutical Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by Qilu Pharmaceutical Co., Ltd.

• A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®
  NCT07062978 · Phase: Phase 3 · Ages: 50 Years to 85 Years · Sex: Female · 1 location
• A Phase 3 Clinical Study of QL2106 Injection
  NCT07511647 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors
  NCT06403735 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer
  NCT06686576 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis
  NCT06406205 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 10 locations
• A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer
  NCT07079228 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
  NCT06880276 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Qilu Pharmaceutical Co., Ltd. recruiting for?

Qilu Pharmaceutical Co., Ltd. is the lead sponsor of 7 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.